Sole Source BioFire - Gastrointestinal Panel IVD and Respiratory Panel 2.1 IVD
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DEFENSE HEALTH AGENCY HCD WEST
Contract Value
Not provided
Codes & Classification
Solicitation Number
HT941027N0010
NAICS
325413 - In-Vitro Diagnostic Substance Manufacturing
Classification Code
6640
Additional Details
Documents1
The Defense Health Agency (DHA), operating under the Department of Defense, has issued a Special Notice indicating its intent to award a sole source procurement for BioFire Gastrointestinal Panel IVD and Respiratory Panel 2.1 IVD products. This procurement is identified under HT941027N0010 and is classified within the North American Industry Classification System (NAICS) code 325413, which pertains to In-Vitro Diagnostic Substance Manufacturing. The associated Product Service Code is 6640, covering laboratory equipment and supplies.
The primary objective of this procurement is to secure advanced in-vitro diagnostic panels specifically designed for gastrointestinal and respiratory pathogen detection. These panels are critical for timely and accurate diagnosis, supporting the healthcare mission at Camp Humphreys, located in South Korea. The intended outcome is to enhance the diagnostic capabilities of the medical facilities at this location, ensuring rapid and reliable identification of infectious agents to support patient care and operational readiness.
This notice serves as a declaration of the agency’s intent to negotiate and award this requirement on a sole source basis, meaning that only one source—presumably the manufacturer or authorized distributor of the BioFire panels—will be considered for this contract. There are no set-aside provisions for small businesses or other socioeconomic categories, reflecting the specialized and proprietary nature of the required products.
The procurement is managed by the Defense Health Agency HCD West office. Interested parties seeking further information or wishing to express interest in this opportunity may contact the designated contracting officials: Susan Fujita ([email protected], 808-433-9506) or CHA-ON Gordon ([email protected], 726-203-0109).
The notice was posted on August 11, 2026, with a response deadline of November 23, 2026. Additional details, including the official Notice of Intent to Sole Source, are available via the SAM.gov opportunity listing (Opportunity ID: 53a31bda208742218b0b825315c51a87).
Contractors with capabilities in in-vitro diagnostic substance manufacturing, particularly those with access to or authorization for BioFire’s proprietary panels, may review the attached documentation for further context. However, due to the sole source nature of this procurement, competition is limited, and only the specified source will be considered unless compelling capability statements are submitted that demonstrate the ability to meet all technical and regulatory requirements.
This procurement is expected to remain consistent throughout its lifecycle, focusing on the supply of the specified diagnostic panels to support ongoing healthcare operations at Camp Humphreys.